Lung Cancer Clinical Trials

Find Lung Cancer Clinical Trials Near You

GUIAR: PromotinG Lung Cancer screenIng Awareness and Implementation in Hispanics/Latinx Head and Neck canceR Survivors

Status: Recruiting
Location: See location...
Intervention Type: Behavioral
Study Type: Interventional
Study Phase: Not Applicable
SUMMARY

The purpose of this study is to assess the awareness of eligibility of lung cancer screening in Hispanic/LatinX Head and Neck Cancer (HNC) survivors using a survey questionnaire; and to understand the barriers to screening using qualitative interviews.

Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
Maximum Age: 80
Healthy Volunteers: f
View:

• Participants must be able to understand, and sign informed consent form.

• Age ≥ 18 years.

• Participants must self-identify as Hispanic/LatinX.

• Individuals must be head and neck cancer survivors (treated locally with surgery, radiation alone, or definitive chemoradiation ≥ 5 years earlier and have no signs/symptoms to suggest recurrence of disease).

• Subjects that meet lung cancer (LC) screening eligibility according to United States Preventive Services Task Force (USPSTF21) and/or National Comprehensive Cancer Network (NCCN). For patients with a history of head and neck cancers, the NCCN recommends annual screening with low dose computerized tomography (LDCT) in those who have had a history of 20 pack years of smoking or more. USPSTF21 LC screening eligibility includes adults ages 50-80 that are current smoker or former smokers that quit within 15 years and have a 20 pack-year history or more of smoking.

Locations
United States
Florida
University of Miami
RECRUITING
Miami
Contact Information
Primary
Coral Olazagasti, MD
cxo379@med.miami.edu
305-243-4334
Time Frame
Start Date: 2024-04-11
Estimated Completion Date: 2029-04-30
Participants
Target number of participants: 44
Treatments
Experimental: Lung Cancer Screening Education Group
Participants in this group will receive intensive lung cancer screening and tobacco cessation education for up to two years.
Other: Standard of Care Control Group
Participants in this group will receive the standard of care treatment for up to two years.
Related Therapeutic Areas
Sponsors
Leads: University of Miami
Collaborators: National Cancer Institute (NCI), LUNGevity Foundation

This content was sourced from clinicaltrials.gov